What Researchers Did
The researchers treated 52 people with advanced head and neck cancer using radiowave heat therapy combined with cobalt radiotherapy and/or radioactive gold grain implants.
What They Found
This retrospective study of 52 advanced head and neck cancer cases reported complete resolution of primary and secondary lesions in 94% of cases after 434-MHz radiowave hyperthermia combined with radiotherapy, with a three-year survival rate of 54%. The authors also looked back at comparable series. In one, treated with hyperbaric oxygen and cobalt, the resolution rate was 62.5% and three-year survival was 29%. In another, treated with conventional supervoltage therapy, the resolution rate was 36.5% and three-year survival was 19%. The abstract does not report a statistical test for these comparisons.
What This Means for Canadian Patients
The abstract describes outcomes in advanced head and neck cancer after heat therapy combined with radiotherapy, and gives figures for a comparison group treated with hyperbaric oxygen and cobalt. It does not describe how the hyperbaric treatment was delivered. Because the comparisons were not tested statistically, these figures cannot show that one treatment works better than another.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The comparison groups came from separate earlier series rather than from patients assigned at random, and the abstract reports no statistical test, so the differences in resolution and survival may reflect other factors.